Ventas (VTR) Stock Price, News & Analysis

Company Overview

Ventas, Inc. (NYSE: VTR) is a real estate investment trust focused on healthcare and senior housing properties. The company owns, manages and develops a diversified portfolio of healthcare-related real estate, including senior living communities, medical office buildings, life science and innovation centers, and other properties serving healthcare providers and institutions.

Ventas generally leases its properties to healthcare operators, physicians, health systems, universities and research organizations. Its senior housing portfolio includes independent living, assisted living and memory care communities, while its medical office and life science properties support outpatient care, medical research and related services.

Founded in 1998, Ventas serves markets primarily in the United States, with additional investments in Canada and the United Kingdom. The company is led by Debra A. Cafaro, who has served as its chief executive officer since 1999.

Key Stats

• Today's Range: $86.17 to $87.90
• 50-Day Range: $79.96 to $93.84
• 52-Week Range: $68.15 to $101.60
• Volume: 2.46 million shs
• Average Volume: 3.57 million shs
• Market Capitalization: $44.55 billion
• P/E Ratio: 23.59
• Dividend Yield: 2.39%
• Price Target: $98.91
• Consensus Rating: Moderate Buy

Ventas Stock Analysis - MarketRank™

Ventas scored higher than 94% of companies evaluated by MarketBeat, and ranked 22nd out of 188 stocks in the real estate sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Ventas has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on no strong buy ratings, 18 buy ratings, 3 hold ratings, and no sell ratings.

Upside Potential

Ventas has a consensus price target of $98.91, representing about 13.9% upside from its current price of $86.86.

Amount of Analyst Coverage

Ventas has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 10.03%

Earnings Growth

Earnings for Ventas are expected to grow by 10.03% in the coming year, from $3.89 to $4.28 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Ventas is 23.59, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.82.

Price to Earnings Ratio vs. Sector

The P/E ratio of Ventas is 23.59, which means that it is trading at a less expensive P/E ratio than the Real Estate sector average P/E ratio of about 27.87.

Price to Earnings Growth Ratio

Ventas has a PEG Ratio of 3.39. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Ventas has a P/B Ratio of 3.24. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.23% of the float of Ventas has been sold short.

Short Interest Ratio / Days to Cover

Ventas has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Ventas has recently decreased by 16.57%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Ventas pays a meaningful dividend of 2.40%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Ventas has only been increasing its dividend for 1 years.

Dividend Coverage

The dividend payout ratio of Ventas is 385.19%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, Ventas will have a dividend payout ratio of 48.60% next year. This indicates that Ventas will be able to sustain or increase its dividend.

News and Social Media

• Score: 4.2 / 5
• News Sentiment: 0.76

News Sentiment

Ventas has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Real Estate companies.

News Coverage This Week

MarketBeat has tracked 7 news articles for Ventas this week, compared to 4 articles on an average week.

Search Interest

8 people have searched for VTR on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.

MarketBeat Follows

5 people have added Ventas to their MarketBeat watchlist in the last 30 days. This is an increase of 67% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Ventas insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.53% of the stock of Ventas is held by insiders.

Percentage Held by Institutions

94.18% of the stock of Ventas is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/29/2026
• Record date for 10/15 Dividend: 9/30/2026
• Ex-Dividend for 10/15 Dividend: 9/30/2026
• Dividend Payable: 10/15/2026
• Today: 10/24/2026
• Next Earnings (Confirmed): 10/27/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Real Estate
• Industry: Healthcare REITs
• Sub-Industry: Healthcare REITs
• Current Symbol: NYSE:VTR
• CIK: 740260
• Web: www.ventasreit.com
• Phone: (877) 483-6827
• Fax: 302-655-5049
• Employees: 542
• Year Founded: 1998

Price Target and Rating

• Average Price Target for Ventas: $98.91
• High Price Target: $114.00
• Low Price Target: $82.00
• Potential Upside/Downside: +13.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.86
• Research Coverage: 21 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.54
• Trailing P/E Ratio: 23.59
• Forward P/E Ratio: 22.33
• P/E Growth: 3.39
• Net Income: $251.38 million
• Net Margins: 4.08%
• Pretax Margin: 3.27%
• Return on Equity: 1.99%
• Return on Assets: 0.94%

Debt

• Debt-to-Equity Ratio: 0.86
• Current Ratio: 0.44
• Quick Ratio: 0.44

Sales & Book Value

• Annual Sales: $5.83 billion
• Price / Sales: 7.64
• Cash Flow: $3.46 per share
• Price / Cash Flow: 25.11
• Book Value: $26.79 per share
• Price / Book: 3.24

Miscellaneous

• Outstanding Shares: 512,950,000
• Free Float: 510,227,000
• Market Cap: $44.55 billion
• Optionable: Optionable
• Beta: 0.72